Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 159Observational 2

Sponsor

Cancer Type

Breast 16Thoracic 10Gastrointestinal 10Gynecologic 6Other 2Head & Neck 2Tumor-Agnostic 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Salivary Gland Neoplasms 1Ovarian Neoplasms 1Neurotoxicity Syndromes 1Lung Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Surveys and Questionnaires 40Blood Specimen Collection 30Radiotherapy 20Immunohistochemistry 13Gene Expression Profiling 12Radiotherapy, Intensity-Modulated 11Cisplatin 11Surgical Procedures, Operative 10Biopsy 10Drug Therapy 9Cetuximab 9Ultrasonography 8Thyroidectomy 8Observation 8Transurethral Resection of Prostate 7Nivolumab 7Interviews as Topic 7pembrolizumab 6Therapeutics 6Radiation 6Polymerase Chain Reaction 6Immunotherapy 6Biopsy, Fine-Needle 6Positron Emission Tomography Computed Tomography 5Microarray Analysis 5Liquid Biopsy 5Iodine-131 5Docetaxel 5Chemoradiotherapy 5Tissue Banks 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Paclitaxel × Head & Neck × Clear all
NCT04672772 2022-03-23

Cetuximab Plus Paclitaxel as First Line for Recurrent and/or Metastatic SCCHN: Real World Data.

Grupo Español de Tratamiento de Tumores de Cabeza y Cuello

Completed
531 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT00003569 2013-01-31

Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel

Roswell Park Cancer Institute

Completed
2 enrolled
GynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Salivary Gland Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡